BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 117719
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.117719
Figure 5
Figure 5 Barriers to translating artificial intelligence models into clinical chronic kidney disease care. Overview of technical, organizational, regulatory, equity, and infrastructure barriers that limit the progression of artificial intelligence models from development to real-world clinical impact in chronic kidney disease care. AUROC: Area under the receiver operating characteristic; AI: Artificial intelligence; FDA: United States Food and Drug Administration; EU: European Union; LMIC: Low-and middle-income countries.


Write to the Help Desk